16p11.2 haploinsufficiency reduces mitochondrial biogenesis in brain endothelial cells and alters brain metabolism in adult mice
Alexandria Béland-Millar, Alexia Kirby, Yen Bach Truong, Julie Ouellette, Sozerko Yandiev, Khalil Bouyakdan, Chantal A. Pileggi, Shama Naz, Melissa Yin, Micaël Carrier, Pavel Kotchetkov, Marie‐Kim St‐Pierre, Marie‐Ève Tremblay, Julien Courchet, Mary‐Ellen Harper, Thierry Alquier, Claude Messier, Adam J. Shuhendler, Baptiste Lacoste
Abstract
Neurovascular abnormalities in mouse models of 16p11.2 deletion autism syndrome are reminiscent of alterations reported in murine models of glucose transporter deficiency, including reduced brain angiogenesis and behavioral alterations. Yet, whether cerebrovascular alterations in 16p11.2 df/+ mice affect brain metabolism is unknown. Here, we report that anesthetized 16p11.2 df/+ mice display elevated brain glucose uptake, a phenomenon recapitulated in mice with endothelial-specific 16p11.2 haplodeficiency. Awake 16p11.2 df/+ mice display attenuated relative fluctuations of extracellular brain glucose following systemic glucose administration. Targeted metabolomics on cerebral cortex extracts reveals enhanced metabolic responses to systemic glucose in 16p11.2 df/+ mice that also display reduced mitochondria number in brain endothelial cells. This is not associated with changes in mitochondria fusion or fission proteins, but 16p11.2 df/+ brain endothelial cells lack the splice variant NT-PGC-1α, suggesting defective mitochondrial biogenesis. We propose that altered brain metabolism in 16p11.2 df/+ mice is compensatory to endothelial dysfunction, shedding light on previously unknown adaptative responses.